Abstract
Cardiac failure is the clinical syndrome that results when the heart is unable to pump blood in an amount that adequately meets the metabolic needs of the body. It is the end result of a heterogeneous group of disorders that, in most cases, directly or indirectly impair myocardial contractility. Cardiac failure also can occur when the normal myocardium is presented suddenly with a load that exceeds its capacity and when ventricular filling is restricted. Implicit in the definition of cardiac failure is the requirement that an abnormality of cardiac function induces the basic hemodynamic consequences of reduction of cardiac output and increase in venous pressure behind one or both ventricles. This is in contrast to the low-output states due to diminished systemic venous return and the congestive states that accompany primary renal and hepatic disorders. The recognition of heart failure rests on the identification of a group of characteristic clinical findings that vary greatly depending on whether the failure is acute or chronic, predominantly left or right sided and low or high output in nature. The variability of the clinical features arises in large part from the fact that they result both from the underlying hemodynamic abnormality and from the compensatory mechanisms that are invoked when myocardial performance is impaired.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Braunwald E, Ross J Jr, Sonnenblick EH: Mechanisms of Contraction of the Normal and Failing Heart. Little, Brown, Boston, 1968, p 77.
Mason DT et al: Clinical determination of left ventricular contractility by hemodynamics and myocardial mechanics. In: Yu PN, Goodwin JF (eds) Progress in Cardiology. Lea and Febiger, Philadelphia, 1972, p 121.
Ross J Jr et al: Left ventricular performance during muscular exercise in patients with and without cardiac dysfunction. Circulation 34:597, 1966.
Diamond G, Forrester JS: Effects of coronary artery disease and acute myocardial infarction on left ventricular compliance in man. Circulation 45:11, 1972.
Chatterjee K, Parmley WW: The role of vasodilator therapy in heart failure. Prog Cardiovasc Dis 19:310,1977.
Mason DT et al: Alterations of hemodynamics and myocardial dynamics in patients with congestive heart failure. Pathophysiologic mechanisms and assessment of cardiac function and ventricular contractility. Prog Cardiovasc Dis 12:507, 1970.
Cohn JN: Physiologic basis of vasodilator therapy for heart failure. Am J Med 71:135, 1981.
Levine TB et al: Activity of the symathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol 49:1659, 1982.
Grancis GS et al: Response of plasma norepinephrine and epinephrine to dynamic exercise in patients with congestive heart failure. Am J Cardiol 49:1152, 1982.
Ross J Jr: Afterload mismatch and preload reserve: a conceptual framework for the analysis of ventricular function. Prog Cardiovasc Dis 18:255, 1976.
Franciosa J A et al: Improved left ventricular function during nitroprusside infusion in acute myocardial infarction. Lancet 1:650, 1972.
Chatterjee K et al: Oral hydralazine for chronic refractory heart failure. Circulation 54:879, 1976.
Colucci WS et al: Chronic therapy of heart failure with prazosin: a randomized double-blind trial. Am J Cardiol 45:337, 1980.
Braunwald E: Control of myocardial oxygen consumption: physiologic and clinical considerations. Am J Cardiol 27:416, 1971.
Braunwald E et al: An analysis of the cardiac response to exercise. Circ Res 20:44, 1962.
Goldstein RE et al: Impairment of autonomically mediated heart rate control in patients with cardiac dysfunction. Circ Res 36:571, 1975.
Corday E, Lang FW: Altered physiology associated with cardiac arrhythmias. In: Hurst JW (ed) The Heart. McGraw Hill, New York, 1978, pp 630–631.
Boerth RC, Covell JW, Pod PE, Ross J Jr: Increased myocardial oxygen consumption and contractile state associated with increased heart rate in dogs. Circ Res 24:725, 1969.
Ricci D et al: Role of tachycardia as an inotropic stimulus in man. J Clin Invest 63:695, 1979.
De Maria A et al: Systematic correlation of cardiac chamber size and ventricular performance determined with echocardiography and alterations in heart rate in normal persons. Am J Cardiol 43:1, 1979.
Vatner SF, Braunwald E: Cardiac frequency-control and adjustments to alterations. Prog Cardiovasc Dis 14:431, 1972.
Moraski RR et al: Left ventricular function in patients with and without myocardial infarction and one, two or three vessel coronary artery disease. AmJ Cardiol 35:1010, 1975.
Mason DT et al: Comparison of the contractile state of the normal, hypertrophied and failing heart in man. In: Alpert NR (ed) Cardiac Hypertrophy. Academic Press, New York, 1971, p 433.
Escher DJW: Types of pacemakers and their complications. Circulation 47:119, 1973.
Dalen JE, Haynes FW, Dexter L: Life expectancy with atrial septal defect. J Am Med Assoc 200:442, 1967.
Ross J Jr: Left ventricular function and the timing of surgical treatment in valvular heart disease. Ann Intern Med 94:498, 1981.
Henry WL et al: Evaluation of aortic valve replacement in patients with valvular aortic stenosis. Circulation 61:814, 1980.
Schuler G et al: Serial noninvasive assessment of left ventricular hypertrophy and function after surgical correction of aortic regurgitation. Am J Cardiol 44:585, 1979.
Kloster FE: Diagnosis and management of complications of prosthetic heart valves. Am J Cardiol 35:872, 1975.
Frank S, Johnson A, Ross J Jr: Natural history of valvular aortic stenosis. Br Heart J 35:41, 1973.
Smith N, McAnulty JH, Rahimtoola SH: Severe aortic stenosis with impaired left ventricular function and clinical heart failure: results of valve replacement. Circulation 58:255, 1978.
Segal J, Harvey WP, Hufnagel C: A clinical study of one hundred cases of severe aortic insufficiency. Am J Med 21:200, 1956.
Rapaport E: Natural history of aortic and mitral valve disease. Am J Cardiol 35:221, 1975.
Gault JH, Covell JW, Braunwald E, Ross J Jr: Left ventricular performance following correction of free aortic regurgitation. Circulation 42:773, 1970.
Schuler G et al: Temporal response of left ventricular performance to mitral valve surgery. Circulation 59:1218, 1979
Borer JS et al: Exercise-induced left ventricular dysfunction in symptomatic and asymptomatic patients with aortic regurgitation: assessment with radionuclide cineangiography. Am J Cardiol 42:351, 1978.
Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on morbidity in hypertension. J Am Med Assoc 202:1028, 1967.
Hypertension Detection and Follow-up Program Cooperative Group: Five year findings of the Hypertension Detection and Follow-up Program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. J Am Med Assoc 242:2562, 1979.
Schlant RC, Tsagaris TS, Robertson RJ Jr: Studies on the acute cardiovascular effects of intravenous sodium nitroprusside. Am J Cardiol 9:51, 1962.
Kleiger JH, Dirks JF: Medication compliance in chronic asthmatic patients. J Asthma Res 16:93, 1979.
Stephen SA: Unwanted effects of propranolol. Am J Cardiol 18:463, 1966.
Braunwald E et al: Idiopathic hypertrophic subaortic stenosis. Circulation 29/30 (Suppl IV): 1, 1964.
Markiewicz W et al: Normal myocardial contractile state in the presence of quinidine. Circulation 53:101, 1976.
Kayden HJ, Brodie BB, Steele JM: Procainamide: a review. Circulation 15:118, 1952.
Podrid PJ, Schoeneberger A, Lown B: Congestive heart failure caused by oral disopyramide. N Engl J Med 302:614, 1980.
Leahoy EJ Jr et al: Interaction between digoxin and quinidine. J Am Med Assoc 240:533, 1978.
Mungall DR et al: Effects of quinidine on serum digoxin concentration. Ann Intern Med 93:689, 1980.
Koster RW, Wellens HJJ: Quinidine-induced ventricular flutter and fibrillation without digitalis therapy. Am J Cardiol 38:519, 1976.
Jensen D et al: Improvement in ventricular function during exercise studied with radionuclide ventriculography after cardiac rehabilitation. Am J Cardiol 46:770, 1980.
Verani MS et al: Effects of exercise training on left ventricular performance and myocardial perfusion in patients with coronary artery disease. Am J Cardiol 47:797, 1981.
Harvey RM et al: Some effects of digoxin upon the heart and circulation in man: digoxin in left ventricular failure. Am J Med 7:439, 1949.
Ferrer MI, Convoy RJ, Harvey RM: Some effects of digoxin on the heart and circulation in man: digoxin in combined ventricular failure. Circulation 21:372, 1960.
Bloomfield RA et al: The effects of cardiac glycosides upon the dynamics of the circulation in congestive heart failure. J Clin Invest 27:588, 1948.
Hull SM, Mackintosh A: Discontinuation of maintenance digoxin therapy in general practice. Lancet 2:1054, 1977.
Johnston GD, McDevitt DG: Is maintenance digoxin necessary in patients with sinus rhythm? Lancet 1:567, 1979.
Beller GA et al: Digitalis intoxication. A prospective clinical study with serum level correlations. N Engl J Med 284:989, 1971.
Cohn K et al: Variability of hemodynamic responses to acute digitalization in chronic cardiac failure due to cardiomyopathy and coronary artery disease. Am J Cardiol 35:461, 1975.
Arnold SB et al: Long-term digitalis therapy improves left ventricular function in heart failure. N Engl J Med 303:1443, 1980.
Kleiman JH et al: Effect of digitalis on normal and abnormal left ventricular segmental dynamics. Am J Cardiol 43:1001, 1979.
Covell JW et al: Studies on digitalis. Effects on myocardial oxygen consumption. J Clin Invest 1535, 1966.
Beiser GD et al: Studies on digitalis XVII. Effects of ouabain on the hemodynamic response to exercise in patients with mitral stenosis in normal sinus rhythm. N Engl J Med 278, 1968.
Doherty JE: Digitalis glycosides. Ann Intern Med 79:229, 1973.
Braunwald E et al: Studies on digitalis: observations in man on the effects of digitalis preparations on the contractility of the non-failing heart and on total peripheral resistance. J Clin Invest 40:52, 1961.
McHenry PL: Exercise stress testing: methods, protocols, measurements and new indices. In: Advances in Heart Disease, vol II. Grune and Stratton, New York, 1978, pp 273–306.
Silber EN, Katz LM: The treatment of heart failure. In: Silber EN, Katz LN (eds) Heart Disease. Macmillan, New York, 1975, pp 1145.
Ogilvie R, Reedy J: An educational program in digitalis therapy. J Am Med Assoc 222:50, 1972.
Williams JF Jr, Klocke FJ, Braunwald E: Studies on digitalis XIII. A comparison of the effects of potassium on the inotropic and arrhythmia-producing actions of ouabain. J Clin Invest 45:346, 1966.
Koch-Weser J: Serum drug concentrations as therapeutic guides. N Engl J Med 287:227, 1972.
Doherty JE, Perkins WH: Digoxin metabolism in hypo and hyperthyroidism. Studies with titrated digoxin in thyroid disease. Ann Intern Med 64:489, 1966.
Surawicz B, Mortelman S: Factors affecting individual tolerance to digitalis. In: Fisch C, Surawicz B (eds) Digitalis. Grune and Stratton, New York, 1969, p 127.
Baum GL et al: Digitalis toxicity in chronic cor pulmonale. South Med J 49:1037, 1956.
Rodensky PL, Wasserman F: Observations on digitalis intoxication. Arch Intern Med 108:171, 1961.
Hudson LD et al: Arrhythmias associated with acute respiratory failure in patients with chronic airway obstruction. Chest 63:661, 1973.
Collins JM et al: The cardiotoxicity of isoprenaline during hypoxia. Br J Pharmacol 36:35, 1969.
Camarata SJ, Weil MH, Hanashiro PK: Cardiac arrest in the critically ill. A study on predisposing causes in 132 patients. Circulation 44:688, 1971.
Green LH, Smith TW: The use of digitalis in patients with pulmonary disease. Ann Intern Med 87:459, 1977.
Klein MD et al: Comparison of serum digoxin level measurement with acetylstrophanthidin tolerance testing. Circulation 49:1053, 1974.
Beller GA et al: Cardiac and circulatory effects of digitalis during chronic hypoxia in intact conscious dogs. Am J Physiol 229:270, 1975.
Ferrer MI et al: Some effects of digoxin upon the heart and circulation in man: digoxin in chronic cor pulmonale. Circulation 1:161, 1950.
Cattell M, Gold H: The influence of digitalis glycosides on the force of contraction of mammalian cardiac muscle. J Pharmacol Exp Ther 62:116, 1938.
Jozek V, Schrizen F: Hemodynamic effect of deslanoside at rest and during exercise in patients with chronic bronchitis. Br Heart J 35:2, 1973.
Linde LM et al: Pulmonary and systemic hemodynamic effects of cardiac glycosides. Am Heart J 76:356, 1968.
Fisch C, Knoebel SB: Recognition and therapy of digitalis intoxication. Prog Cardiovasc Dis 12:71, 1970.
Fisch C: Relation of electrolyte disturbances to cardiac arrhythmias. Circulaton 47:408, 1973.
Whang R: Hyperkalemia: diagnosis and treatment. J Med Sci 272:19, 1976.
Helfant RH, Scherlag BJ, Damato AN: The electrophysiological properties of diphenylhydantoin sodium as compared to procainamide in the normal and digitalis-intoxicated heart. Circulation 34:108, 1967.
Resnekov L: Present status of electroversion in the management of cardiac dysrhythmias. Circulation 47:1356, 1973.
Marcus FI: Use of digitalis in acute myocardial infarction. Circulation 62:17, 1980.
Rahimtoola SH et al: Effects of ouabain on impaired left ventricular function in acute myocardial infarction. N Engl J Med 287:527, 1972.
Rahimtoola SH, Gunnar RM: Digitalis in acute myocardial infarction: help or hazard? Ann Intern Med 82:234, 1974.
Kumar R et al: Experimental myocardial infarction. VI. Efficacy and toxicity of digitalis in acute and healing phase in intact conscious dogs. J Clin Invest 49:358, 1970.
Kerber RE et al: Effect of inotropic agents on the localized dyskinesis of acutely ischemic myocardium. Circulation 49:1038, 1974.
Morrison J et al: Digitalis and myocardial infarction in man. Circulation 62:8, 1980.
Ku DD, Lucchesi BR: Ischemic-induced alterations in cardiac sensitivity to digitalis. Eur J Pharmacol 57:135, 1979.
Lown B et al: Sensitivity to digitalis drugs in acute myocardial infarction. Am J Cardiol 30:388, 1972.
Moss AJ et al: Digitalis-associated cardiac mortality after myocardial infarction. Circulation 64:1150, 1981.
Humphries JP: Survival after myocardial infarction: prognosis and management. Mod Concepts Cardiovasc Dis 46: 51, 1977.
Schulze RA, Strauss HW, Pi HB: Sudden death in the year following myocardial infarction: relation to ventricular premature contractions in the late hospital phase and left ventricular ejection fraction. Am J Med 62:192, 1977.
Cannon PJ: The kidney in heart failure. N Engl J Med 296:26, 1977.
Porter GA: The role of diuretics in the treatment of heart failure. J Am Med Assoc 244:1614, 1980.
Bennett WM, Porter GA: Efficacy and safety of metolazone in renal failure. J Clin Pharmacol 13:357, 1973.
Frazier HS, Yager H: The clinical use of diuretics. N Engl J Med 288:200, 1973.
Grimm RH Jr et al: Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients. Ann Intern Med 94:7, 1981.
Humes HD: The kidney in congestive heart failure. In: Brenner BM, Stein JH (eds) Sodium and Water Homeostasis. Churchill Livingstone, New York, 1978.
Ramo BW et al: Hemodynamic findings in 123 patients with acute myocardial infarction on admission. Circulation 42:567, 1970.
Swan HJC et al: Catheterization of the heart in man with use of a flow-directed balloon tipped catheter. N Engl J Med 283:447, 1970.
Burch GE: Evidence for increased venous tone in chronic congestive heart failure. Arch Intern Med 98:750, 1956.
Judson WE, Hollander W, Wilkins RW: The effects of intravenous hydralazine on cardiovascular and renal function in patients with and without congestive heart failure. Circulation 8:664, 1956.
Majid PA, Sharma B, Taylor SH: Phentolamine for vasodilator treatment of severe heart failure. Lancet 2:719, 1971.
Guiha NA et al: Treatment of refractory heart failure with infusion of nitroprusside. N Engl J Med 291:587, 1974.
Cohn JN et al: Chronic vasodilator therapy in the management of cardiogenic shock and intractable left ventricular failure. Ann Intern Med 81:777, 1974.
Chatterjee J et al: Hemodynamic and metabolic responses to vasodilator therapy in acute myocardial infarction. Circulation 48:1183, 1973.
Taylor WR et al: Hemodynamic effects of nitroglycerin ointment in congestive heart failure. Am J Cardiol 38:469, 1976.
Cohn JN et al: Role of vasoconstrictor mechanisms in the control of left ventricular performance of the normal and damaged heart. Am J Cardiol 44:1019, 1979.
Cohn JN, Franciosa JA: Selecton of vasodilator, inotropic or combined therapy for the management of heart failure. Am J Med 65:181, 1978.
Greenberg BH et al: Beneficial effects of hydralazine in severe mitral regurgitation. Circulation 58:273, 1978.
Greenberg BH et al: Beneficial effects of hydralazine on rest and exercise hemodynamics in patients with chronic severe aortic insufficiency. Circulation 62:49, 1980.
Flaherty JT et al: Effect of intravenous nitroglycerin on left ventricular function and ST segment changes in acute myocardial infarction. Br Heart J 38:612, 1976.
Kelly DT et al: Use of phentolamine in acute myocardial infarction associated with hypertension and left ventricular failure. Circulation 47:723, 1973.
Cohn JN, Franciosa JA: Vasodilator therapy of cardiac failure. N Engl J Med 297:27. 1977.
Chatterjee K et al: Oral hydralazine in chronic heart failure: sustained beneficial hemodynamic effects. Ann Intern Med 92:600, 1980.
Franciosa JA, Cohn JN: Sustained hemodynamic effects without tolerance during long-term isosorbide dinitrate treatment of chronic left ventricular failure. Am J Cardiol 45:648, 1980.
Thadani U et al: Tolerance to the circulatory effects of oral isosorbide dinitrate: rate of development and cross-tolerance to glyceryl trinitrate. Circulation 61:526, 1980.
Packer M et al: Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure. Circulation 59:531, 1979.
Packer M et al: Hemodynamic characterization of tolerance to long-term hydralazine therapy in severe chronic heart failure. N Engl J Med 306:57, 1982.
Franciosa JA, Ziesche S, Wilen M: Functional capacity of patients with chronic left ventricular failure. Relationship of bicycle exercise performance to clinical and hemodynamic characterization. Ann J Med 67:460, 1979.
Massie B et al: Long-term vasodilatory therapy for heart failure: clinical response and its relationship to hemodynamic measurements. Circulation 63:269, 1981.
Cohn JN, Rodriguera E, Guiha NH: Left ventricular function in hypertensive heart disease. In: Onesti G, Kim KE (eds) Hypertension Mechanisms and Management. Grune and Stratton, New York, 1973, p 191.
Cohn JN, Burke LP: Nitroprusside. Ann Intern Med 91:752, 1979.
Hoffman JIE: Determinants and prediction of transmural myocardial perfusion. Circulation 58:381, 1978.
Chiariello M et al: Comparison between the effects of nitroprusside and nitroglycerin on ischemic injury during acute myocardial infarction. Circulation 54:766, 1976.
Forrester JS et al: Medical therapy of acute myocardial infarction by application of hemodynamic subsets. N Engl J Med 295:1356, 1976.
Chatterjee MB et al: Effects of vasodilator therapy for severe pump failure in acute myocardial infarction on short-term and late prognosis. Circulation 53:797, 1976.
Cohn JN et al: Effect of short-term infusion of sodium nitroprusside on mortality rate in acute myocardial infarction complicated by left ventricular failure. N Engl J Med 306:1129, 1982.
Wayman SM: Nitroprusside in myocardial infarction. N Engl J Med 306:1168, 1982.
Durrer JD et al: Effect of sodium nitroprusside on mortality in acute myocardial infarction. N Engl J Med 306:1121, 1982.
Ganz W, Swan HJC: Measurement of blood flow by thermodilution. Am J Cardiol 29:241, 1972.
Lopez-Sendon J, Coma-Canella I, Gamallo C: Sensitivity and specificity of hemodynamic criteria in the diagnosis of acute right ventricular infarction. Circulation 64:515, 1981.
Friedman AM, Stern L: Identification of mitral regurgitation following acute myocardial infarction by hemodynamic monitoring. Chest 79:252, 1980.
Abernathy WS: Complete heart block caused by the Swan-Ganz catheter. Chest 65:349, 1974.
Castellanos A et al: Left fascicular blocks during right-heart catheterization using the Swan-Ganz catheter. Circulation 64:1271, 1981.
Smith WR, Glauser FL, Jemison P: Ruptured chordae of the tricuspid valve. The consequence of flow-directed Swan-Ganz catheterization. Chest 70:790, 1976.
Pape LA et al: Fatal pulmonary hemorrhage after use of the flow-directed balloon-tipped catheter. Ann Intern Med 90:344, 1979.
Foote GA, Schabel SI, Hodges M: Pulmonary complications of the flow-directed balloon-tipped catheter. N Engl J Med 290:927, 1974.
Voei G et al: Retrival of entrapped and knotted balloon-tipped catheters from the right heart. Ann Intern Med 92:638, 1980.
Cohn JN: Blood pressure measurement in shock. Mechanism of inaccuracy in auscultatory and palpatory methods. J Am Med Assoc 199:972, 1967.
Bodenheimer MM et al: Effect of progressive pressure reduction with nitroprusside on acute myocardial infarction in humans. Ann Intern Med 94:435, 1981.
Packer M et al: Rebound hemodynamic events after abrupt withdrawal of nitroprusside in patients with severe chronic heart failure. N Engl J Med 301:1193, 1979.
Pierpont G et al: Effects of vasodilators on pulmonary hemodynamics and gas exchange in left ventricular failure. Am Heart J 88:256, 1980.
Miller RR, Vismara LA, Williams DA: Pharmacological mechanisms for left ventricular unloading in clinical congestive heart failure. Circ Res 39:127, 1976.
Dunkman WB et al: Clinical hemodynamic results of intraaortic balloon pumping and surgery for cardiogenic shock. Circulation 46:465, 1972.
Hagemeijer F et al: Effectiveness of intraaortic balloon pumping without cardiac surgery for patients with severe heart failure secondary to a recent myocardial infarction. Am J Cardiol 40:951, 1977.
Awan NA et al: Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Circulation 56:346, 1977.
Walsh WF, Greenberg BH: Results of long-term vasodilator therapy in patients with refractory congestive heart failure. Circulation 64:499, 1981.
Massie BM, Kramer B, Haughom F: Acute and long-term effects of vasodilator therapy on resting and exercise hemodynamic and exercise tolerance. Circulation 64:1218, 1981.
Hindman MC et al: Rest and exercise hemodynamic effects of oral hydralazine in patients with coronary artery disease and left ventricular dysfunction. Circulation 61:751, 1980.
Aronow WS et al: Effect of prazosin vs. placebo on chronic left ventricular heart failure. Circulation 59:344, 1979.
Hecht HS et al: Improvement in supine bicycle exercise performance in refractory congestive heart failure after isosorbide dinitrate: radionuclide and hemodynamic evaluation of acute effects. Am J Cardiol 49:133, 1982.
Leier CV, Magorien RD, Desch CE: Hydralazine and isosorbide dinitrate: comparative central and regional hemodynamic effects when administered alone or in combination. Circulation 63:102, 1981.
Massie B et al: Hemodynamic advantage of combined administration of hydralazine orally and nitrates non-parenterally in the vasodilator therapy of chronic heart failure. Am J Cardiol 40:794, 1977.
Abrams J: Nitroglycerin and long-acting nitrates. N Engl J Med 302:1234, 1980.
Koch-Weser J: Hydralazine. N Engl J Med 295:320, 1976.
Greenberg BH, DeMots H, Murphy E: Arterial dilators in mitral regurgitation: effects on rest and exercise hemodynamics and long-term clinical follow-up. Circulation 65: 181, 1982.
Packer M et al: Dose requirements of hydralazine in patients with severe chronic congestive heart failure. Am J Cardiol 46:655, 1980.
Mehta J et al: Comparative hemodynamic effects of intravenous nitroprusside and oral prazosin in refractory heart failure. Am J Cardiol 41:925, 1978.
Colucci WS, Williams GH, Braunwald E: Increased plasma norepinephrine levels during prazosin therapy for severe congestive heart failure. Ann Intern Med 93:452, 1980.
Koch-Weser J: Captopril. N Engl J Med 306:214, 1982.
Levine TB, Franciosa JA, Cohn JN: Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure. Circulation 62:35, 1980.
Creager MA, Halperin JL, Bernard DB: Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure. Circulation 64:483, 1981.
Dzau VJ et al: Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure. N Engl J Med 302:1373, 1980.
Kluger J, Cody RJ, Laragh JH: The contributions of sympathetic tone and the renin-angiontensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril). Am J Cardiol 49:1667, 1982.
Curtiss C et al: Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure. Circulation 58:763, 1978.
Packer M et al: Determinants of drug response in severe chronic heart failure. I. Activation of avasoconstrictor forces during vasodilator therapy. Circulation 64:506, 1981.
Maroko PR et al: Factors influencing infarct size following experimental coronary artery occlusions. Circulation 43: 67, 1971.
Goldberg LI, Hsieh Y-Y, Resnekov L: Newer catecholamines for treatment of heart failure and shock: an update on dopamine and a first look at dobutamine. Prog Cardiovasc Dis 19:327, 1977.
Sonnenblick EH, Frishman WH, LeJemtel TH: Dobutamine: a new synthetic cardioactive sympathetic amine. N Engl J Med 300:17, 1979.
Leier CV, Heban PT, Huss P: Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure. Circulation 58:466, 1978.
Goldstein RA, Pasamani ER, Roberts R: A comparison of digoxin and dobutamine in patients with acute infarction and cardiac failure. N Engl J Med 303:846, 1980.
Loeb HS, Bredakis J, Gunnar RM: Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure. Circulation 55, 375, 1977.
Gillespie TA et al: Effects of dobutamine in patients with acute myocardial infarction. Am J Cardiol 39: 588, 1977.
Miller RR et al: Combined dopamine and nitroprusside therapy in congestive heart failure. Circulation 55:881, 1977.
Awan NA, Evenson MK, Needham KE: Hemodynamic effects of oral pirbuterol in chronic severe congestive heart failure. Circulaton 63:96, 1981.
Alousi AA et al: Cardiotonic activity of amrinone. Circ Res 45:666, 1979.
Benotti JR et al: Hemodynamic assessment of amrinone: a new inotropic agent. N Engl J Med 299:1373, 1978.
Benotti JR et al: Effects of amrinone myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease. Circulation 62:28, 1980.
Wynne J et al: Oral amrinone in refractory congestive heart failure. Am J Cardiol 45:1245, 1980.
Weber KT, Andrews V, Janicki JS: Amrinone and exercise performance in patients with chronic heart failure. Am J Cardiol 48:164, 1981.
Klein NA et al: Hemodynamic comparison of intravenous amrinone and dobutamine in patients with chronic congestive heart failure. Am J Cardiol 48:170, 1981.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Martinus Nijhoff Publishers, Boston, The Hague, Dordrecht, Lancaster
About this chapter
Cite this chapter
Williams, E.S., Fisch, C. (1983). Treatment of cardiac failure. In: Rosen, M.R., Hoffman, B.F. (eds) Cardiac therapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3855-0_14
Download citation
DOI: https://doi.org/10.1007/978-1-4613-3855-0_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-3857-4
Online ISBN: 978-1-4613-3855-0
eBook Packages: Springer Book Archive